AI brief of an SEC Form 8-K · Cardio Diagnostics Holdings, Inc. (CDIO)

Cardio Diagnostics Holdings schedules February 19, 2026 investor call and presentation

Neutral Impact 2 of 5 other Written later

Cardio Diagnostics Holdings, Inc. (CDIO) filed an 8-K to announce an investor conference call on February 19, 2026 to discuss its current status, recent developments and strategic priorities. The filing includes a slide presentation as Exhibit 99.1 but no financial results, and the company states it is not providing guidance on future results, so shareholders can use the materials to review reimbursement, clinical data and lab progress.

Key points

  • Investor call set for 3 p.m. Central Standard Time on February 19, 2026, covering recent clinical data, reimbursement progress and strategic initiatives
  • Presentation furnished as Exhibit 99.1; replay to be available on the investor relations website for a limited time
  • Presentation says Medicare coverage process is ongoing and out-of-network billing capability is expected in Q2 2026
  • The company states it is not making projections or providing guidance on future consolidated results

The filing

CompanyCardio Diagnostics Holdings, Inc. (CDIO)
Form8-K, current report
Filed with the SECFeb 19, 2026, 8:00 AM ET
Accession number0001079973-26-000239

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 19, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.